Discontinuation of risperidone in Alzheimer's disease

Comment

D P Devanand et al. N Engl J Med. 2013.

. 2013 Jan 10;368(2):187-8.

doi: 10.1056/NEJMc1214030.

No abstract available

Comment on

Relapse risk after discontinuation of risperidone in Alzheimer's disease.
Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B. Devanand DP, et al. N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058. N Engl J Med. 2012. PMID: 23075176 Free PMC article. Clinical Trial.
Discontinuation of risperidone in Alzheimer's disease.
Gnjidic D, Hilmer SN. Gnjidic D, et al. N Engl J Med. 2013 Jan 10;368(2):186. doi: 10.1056/NEJMc1214030. N Engl J Med. 2013. PMID: 23301738 No abstract available.
Discontinuation of risperidone in Alzheimer's disease.
Power GA. Power GA. N Engl J Med. 2013 Jan 10;368(2):186-7. doi: 10.1056/NEJMc1214030. N Engl J Med. 2013. PMID: 23301739 No abstract available.
Discontinuation of risperidone in Alzheimer's disease.
Ling SM, Bonner AF, McMullen TL. Ling SM, et al. N Engl J Med. 2013 Jan 10;368(2):187. doi: 10.1056/NEJMc1214030. N Engl J Med. 2013. PMID: 23301740 No abstract available.